Iron isomaltoside 1000 clinical trials
Also written Monofer, Ferric derisomaltose and Monoferric.
How each study uses iron isomaltoside 1000 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the iron isomaltoside 1000 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
79 studies that test it; most in 2023 (11)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 30 · Other 50
Pharmacosmos A/S (29) · Yonsei University (6) · China-Japan Friendship Hospital (4) · Oslo University Hospital (2) · Massachusetts General Hospital (1) · Brigham and Women's Hospital (1) · Thomas Jefferson University (1) · Michael Kremke (1)
Often tested with
Tested in the same studies.
Ferric carboxymaltose (3) · Iron sucrose (3) · Iron (1) · Ferrous fumarate (1) · Tranexamic Acid (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 12, 4 in phase 3
Studies that test iron isomaltoside 1000, phase 3 first.
- Dec 2026Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyPhase 3 · Saskatchewan Health Authority - Regina Area
- Mar 2027Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in PregnancyPhase 3 · Women and Infants Hospital of Rhode Island
- Apr 2027Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency AnemiaPhase 3 · Pharmacosmos A/S
- Oct 2027Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN StudyPhase 3 · Hull University Teaching Hospitals NHS Trust
- Nov 2026Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery PatientsPhase 4 · dr. P. Noordzij
- Dec 2026Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac SurgeryPhase 2 · University Health Network, Toronto
- Dec 2026Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.Not applicable · China-Japan Friendship Hospital
- Feb 2027Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis PatientsPhase 4 · Xie Jingyuan, MD
- Jun 2027The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture SurgeryPhase 4 · Soren Overgaard
- Aug 2027The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)Phase 4 · China-Japan Friendship Hospital
Studies
Open first, then newest update. How each study uses iron isomaltoside 1000 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 80
- The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)RecruitingPhase 4China-Japan Friendship HospitalNCT05971732Written as Ferric derisomaltose
- The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of LifeRecruitingPhase 4China-Japan Friendship HospitalNCT05991128Written as Ferric derisomaltose
- The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron DeficiencyRecruitingPhase 4China-Japan Friendship HospitalNCT06427343Written as High-dose ferric derisomaltose
- Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)RecruitingPhase 3AHS Cancer Control AlbertaNCT05407987Written as Ferric derisomaltose
- IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron DeficiencyNot yet recruitingPhase 4Duke UniversityNCT07686692Written as Ferric derisomaltose
- A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting ConditionsRecruitingPhase 1Sichuan Huiyu Pharmaceutical Co., LtdNCT07790562Written as Ferric Derisomaltose Injection
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart FailureRecruitingPhase 3Pharmacosmos A/SNCT06929806Written as Ferric Derisomaltose
- Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron DeficiencyEnrolling by invitationPhase 2Government of JerseyNCT07643818Written as Ferric Derisomaltose
- Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency AnemiaRecruitingPhase 3Pharmacosmos A/SNCT05179226Written as Ferric Derisomaltose
- IRONCARE: Iron Treatment in Older Patients With Hip FracturesNot yet recruitingPhase 4University of AarhusNCT07659184Written as Ferric Derisomaltose
- The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture SurgeryRecruitingPhase 4Soren OvergaardNCT06898814Written as Ferric Derisomaltose
- Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN StudyRecruitingPhase 3Hull University Teaching Hospitals NHS TrustNCT06884280Written as Monofer (iron isomaltoside 1000)
- Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery PatientsRecruitingPhase 4dr. P. NoordzijNCT04913649Written as Ferric Derisomaltose 100 MG/ML
- Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac SurgeryRecruitingPhase 2University Health Network, TorontoNCT06287619Written as Monoferric Injectable Product
- Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac SurgeryNot yet recruitingPhase 4Yonsei UniversityNCT07238972Written as Ferric derisomaltose
- Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.RecruitingNot applicableChina-Japan Friendship HospitalNCT07236788Written as Iron Isomaltoside injection
- The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity SurgeryRecruitingPhase 4Peking Union Medical College HospitalNCT05714007Written as Ferric derisomaltose
- Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in PregnancyRecruitingPhase 3Women and Infants Hospital of Rhode IslandNCT05462704Written as Ferric derisomaltose
- Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyRecruitingPhase 3Saskatchewan Health Authority - Regina AreaNCT05251493Written as Iron Isomaltoside 1000, ferric derisomaltose
- Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis PatientsNot yet recruitingPhase 4Xie Jingyuan, MDNCT06830941Written as Iron isomaltoside
See all 80 studies that test iron isomaltoside 1000 →
As the comparator · 1 — what is tested is compared with iron isomaltoside 1000
Codes
What other systems call iron isomaltoside 1000 · ClinicalTrials.gg INT005816
- MeSH (NLM) C557707iron isomaltoside 1000Confirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3M6325NY1RIRON ISOMALTOSIDE 1000Confirmed FDA, NLM, Wikidata
- Wikidata Q112131611iron isomaltoside 1000Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C92584Iron Isomaltoside 1000Confirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C557707 | iron isomaltoside 1000 | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3M6325NY1R | IRON ISOMALTOSIDE 1000 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q112131611 | iron isomaltoside 1000 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C92584 | Iron Isomaltoside 1000 | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.